Arbutus Biopharma Corp (Pre-Merger)

Not featured in screeners

Not featured in screeners

Insider activity signals

0 activity signals detected for Arbutus Biopharma Corp (Pre-Merger)

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Download results Settings

Naftzger, Christopher Senior Officer of Issuer Officer

Transaction date 31 Dec 2024

Planned purchase

Price

351.85

Quantity 45,915 +36.1%

Value US$1,624,641

Sofia, Michael Joseph Senior Officer of Issuer Officer

Transaction date 2 Feb 2024

Sale

Price

132.18

Quantity 4,227 -48.4%

Value US$1,977,599

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-02-20	2024-12-31	PP Planned purchase	Naftzger, Christopher Senior Officer of Issuer Officer	45,915 +36.1% 351.85 US$1,624,641	45,915 +36.1%	351.85	US$1,624,641
2024-02-05	2024-02-02	S Sale	Sofia, Michael Joseph Senior Officer of Issuer Officer	4,227 -48.4% 132.18 US$1,977,599	4,227 -48.4%	132.18	US$1,977,599